GlaxoSmithKline PLC Stock Target Price and Analyst Consensus
| GSK Stock | USD 36.17 0.38 1.04% |
The current analyst and expert consensus on GlaxoSmithKline PLC is Buy, with 2 strong buy opinions. The current projected GlaxoSmithKline PLC target price consensus is 45.07 with 7 analyst opinions. Check out Macroaxis Advice on GlaxoSmithKline PLC to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way GlaxoSmithKline PLC ADR analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview GlaxoSmithKline PLC executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on GlaxoSmithKline PLC. We strongly encourage you to use your own analysis of GlaxoSmithKline PLC ADR to validate this buy or sell advice. GlaxoSmithKline PLC buy-or-sell recommendation module provides average expert sentiment on the projected GlaxoSmithKline PLC ADR target price to derive its highest and lowest estimates based on projected price volatility of 1.7217.
Lowest Forecast 41.02 | Highest Forecast 50.03 | Target Price 45.07 |
GlaxoSmithKline |
It's important to approach GlaxoSmithKline PLC's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
GlaxoSmithKline PLC Target Price Consensus
GlaxoSmithKline target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. GlaxoSmithKline PLC's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 7 | Buy |
Most GlaxoSmithKline analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand GlaxoSmithKline stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of GlaxoSmithKline PLC ADR, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationGlaxoSmithKline PLC Target Price Projection
GlaxoSmithKline PLC's current and average target prices are 36.17 and 45.07, respectively. The current price of GlaxoSmithKline PLC is the price at which GlaxoSmithKline PLC ADR is currently trading. On the other hand, GlaxoSmithKline PLC's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
GlaxoSmithKline PLC Market Quote on 17th of February 2025
Target Price
Analyst Consensus On GlaxoSmithKline PLC Target Price
GlaxoSmithKline PLC Analyst Ratings
GlaxoSmithKline PLC's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about GlaxoSmithKline PLC stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of GlaxoSmithKline PLC's financials, market performance, and future outlook by experienced professionals. GlaxoSmithKline PLC's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize GlaxoSmithKline PLC price targets
GlaxoSmithKline PLC's stock target price is an estimate of its future price, usually made by analysts. Using GlaxoSmithKline PLC's target price to determine if it is a suitable investment can be done through the following steps:- Look at GlaxoSmithKline PLC's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if GlaxoSmithKline PLC's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional GlaxoSmithKline PLC Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of GlaxoSmithKline PLC is a key component of GlaxoSmithKline PLC valuation and have some predictive power on the future returns of a GlaxoSmithKline PLC.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of GlaxoSmithKline PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Transportation Invested few shares | |
 | Macroaxis Index Invested over 90 shares | |
 | Large Cap ETFs Invested few shares | |
| Size And Style ETFs Invested few shares | |
 | Dividend Beast Invested over 60 shares | |
 | Momentum Invested over 300 shares | |
 | Blockchain Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Hedge Favorites Invested over 100 shares | |
 | FinTech Invested over 30 shares | |
Check out Macroaxis Advice on GlaxoSmithKline PLC to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.